TRAIL‐Induced Apoptosis

Annals of the New York Academy of Sciences - Tập 1171 Số 1 - Trang 50-58 - 2009
Nadia Corazza1, Daniela Kassahn1, Sabine Jakob1, A Badmann1, Thomas Brunner1
1Division of Immunopathology, Institute of Pathology, University of Bern, Bern, Switzerland

Tóm tắt

The death ligand members of the tumor necrosis factor (TNF) family are potent inducers of apoptosis in a variety of cell types. In particular, TNF‐related apoptosis‐inducing ligand (TRAIL) has recently received much scientific and commercial attention because of its potent tumor cell‐killing activity while leaving normal untransformed cells mostly unaffected. Furthermore, TRAIL strongly synergizes with conventional chemotherapeutic drugs in inducing tumor cell apoptosis, making it a most promising candidate for future cancer therapy. Increasing evidence indicates, however, that TRAIL may also induce or modulate apoptosis in primary cells. A particular concern is the potential side effect of TRAIL‐based tumor therapies in the liver. In this review we summarize some of the recent findings on the role of TRAIL in tumor cell and hepatocyte apoptosis.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.271.22.12687

10.1016/1074-7613(95)90057-8

10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T

10.1074/jbc.M909721199

10.1074/jbc.M706078200

10.1369/jhc.3A6112.2004

10.1007/978-1-59745-339-4_16

10.1038/nrm2308

Kavurma M.M., 2008, Trail stimulates proliferation of vascular smooth muscle cells via activation of NF‐kappa B and induction of insulin‐like growth factor‐1 receptor, J. Biol. Chem., 3, 3

10.1158/0008-5472.CAN-06-3896

10.1016/j.cellsig.2006.12.008

10.1074/jbc.M010384200

10.1126/science.278.5339.860

10.1016/S0092-8674(00)80406-7

10.1152/ajpgi.00242.2005

10.4049/jimmunol.169.6.2851

10.1016/j.bbrc.2006.10.163

10.1038/sj.onc.1206842

10.1074/jbc.273.49.33091

10.4161/cbt.3.3.696

10.1172/JCI27726

10.1158/1535-7163.MCT-07-0278

10.1158/0008-5472.CAN-04-1498

10.1007/BF03402036

Ng C.P., 2002, X‐linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor‐related apoptosis‐inducing ligand‐mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria‐derived activator of caspase/direct IAP‐binding protein with low pl (Smac/DIABLO), Mol Cancer Ther., 1, 1051

10.1158/0008-5472.CAN-04-0046

10.1038/5517

10.1073/pnas.85.2.607

10.1038/nm0497-409

10.1016/j.molmed.2007.03.002

10.1002/jcb.21304

10.1038/sj.onc.1210696

10.1158/1078-0432.CCR-05-2635

10.1158/0008-5472.CAN-04-1195

10.4049/jimmunol.178.3.1923

10.1158/1535-7163.MCT-07-0167

10.1158/0008-5472.CAN-04-2488

10.1158/1541-7786.MCR-06-0433

10.1042/bj3480093

10.1128/MCB.20.18.6638-6645.2000

10.1074/jbc.M509560200

10.1074/jbc.M302161200

Leung K.T., 2008, Activation of the JNK pathway promotes phosphorylation and degradation of BimEL a novel mechanism of chemoresistance in T‐cell acute lymphoblastic leukemia, Carcinogenesis, 3, 3

10.1074/jbc.M512627200

10.1038/83416

10.4049/jimmunol.168.3.1356

10.1136/gut.2004.056929

10.1038/75045

10.1172/JCI200419255

10.1073/pnas.040566697

10.1016/j.cell.2007.03.017

10.1038/23730

10.1074/jbc.M102465200

10.1136/gut.2006.118059

10.1073/pnas.0438011100

10.1038/sj.cdd.4401525

Thông tin
Thông tin xuất bản

Annals of the New York Academy of Sciences

Tập 1171 Số 1

50-58

Thông tin tác giả